| 摘要 |
Proposed present invention relates to adenosine A3 receptor ligands of the general formula (I), preferably antagonists, as well as salts, solvates and isomers thereof, and pharmaceutical compositions containing them, to use of compounds of the general formula (I), as well as salts, solvates and isomers thereof, to preparation of compounds of the genera] formula (I) and salts, solvates and isomers thereof, and additionally, to new intermediates of the general formulae (II) and to preparation thereof. |
